Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.34 - $34.28 $20.8 Million - $28.2 Million
821,261 Added 266.33%
1,129,620 $36.3 Million
Q4 2023

Feb 14, 2024

SELL
$25.21 - $34.66 $722,090 - $992,766
-28,643 Reduced 8.5%
308,359 $8.42 Million
Q2 2023

Aug 14, 2023

SELL
$25.15 - $32.86 $8.07 Million - $10.5 Million
-320,746 Reduced 48.76%
337,002 $10.9 Million
Q1 2023

May 15, 2023

SELL
$17.5 - $25.9 $6.58 Million - $9.73 Million
-375,823 Reduced 36.36%
657,748 $17 Million
Q4 2022

Feb 14, 2023

BUY
$13.95 - $19.28 $11.6 Million - $16 Million
828,292 Added 403.5%
1,033,571 $18.6 Million
Q3 2022

Nov 14, 2022

BUY
$14.66 - $18.3 $2.78 Million - $3.47 Million
189,584 Added 1207.93%
205,279 $3.48 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $6.07B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.